We propose to continue to develop and test a self-contained light delivery device for use in photodynamic therapy (PDT) for Barrett's esophagus. This device employs distally located semiconductor lasers at the end of a thin coaxial cable inserted into a balloon catheter. In Phase I, we successfully developed prototype units that produced sufficient light for PDT treatment and evaluated different scattering media to increase the uniformity of the light emission. In Phase II, we intend to design enhancements that produce uniform light distribution and increase the illuminator's flexibility. A light and fluorescence detection system will be incorporated into the balloon's wall. Unit will be tested for safety and efficacy in an animal model. A significant advantage to this source design is that individual segments or spot locations across the illuminator can be turned on or off and the intensity changed during treatment. The light and fluorescence detection systems will allow more uniform treatment and help optimize treatment parameters (fluence, fluence rate, photosensitizer dose, and photosensitizer/light interval) to maximize the PDT effect and minimize toxicity. The diode illuminator will be capable of changing light dosing parameters to fit optimal conditions for any situation including the use of different photosensitizing compounds.

Proposed Commercial Applications

Not Available

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42RR012259-02A1
Application #
6293292
Study Section
Special Emphasis Panel (ZRG1-SSS-8 (62))
Program Officer
Filart, Rosemarie
Project Start
1997-09-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
2
Fiscal Year
2001
Total Cost
$278,132
Indirect Cost
Name
Amt, Inc.
Department
Type
DUNS #
City
Cherry Hill
State
NJ
Country
United States
Zip Code
08003